CompuGroup Medical SE & Co. KGaA header image

CompuGroup Medical SE & Co. KGaA

COPA

Equity

ISIN US20481P1003 / Valor 18229557

Deutsche Boerse AG (2024-09-13)
EUR 12.70-4.51%

CompuGroup Medical SE & Co. KGaA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

CompuGroup Medical SE & Co. KGaA is a company that specializes in developing software solutions to streamline and enhance the medical and administrative processes of healthcare providers. Their software enables electronic communication with patients, ultimately improving efficiency and patient care within the healthcare industry. With a focus on innovation and technology, CompuGroup Medical aims to provide cutting-edge solutions to meet the evolving needs of healthcare professionals and patients alike.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (23.05.2024):

Revenue Overview

In the first quarter of 2024, CompuGroup Medical SE & Co. KGaA reported a slight decline in revenue by 2% year-over-year, primarily due to one-time effects in the telematics infrastructure. However, when adjusted for the effects from the TI connector exchange, the organic revenue growth was positive at 3%. Recurring revenues increased by 7% to EUR 213 million, accounting for 75% of the total revenue.

Earnings Performance

CompuGroup Medical SE & Co. KGaA's adjusted EBITDA for the first quarter of 2024 rose by 1% to EUR 61 million. The adjusted earnings per share also increased to EUR 0.47, supported by the divestiture of the company's business activities in Turkey. The free cash flow for the first three months stood at EUR 59 million, and the debt ratio was reduced from 2.8 times the adjusted EBITDA of the last 12 months as of March 2023 to 2.6 times.

AIS Segment Performance

The AIS segment of CompuGroup Medical SE & Co. KGaA, which now includes the former CHS segment, saw a decrease in revenue to EUR 172 million in the first quarter of 2024, down 6% from the previous year. This decline was due to one-time effects related to the exchange of connectors in the telematics infrastructure in the first quarter of 2023. Adjusted for these effects, organic revenue grew by 3%. Recurring revenues in the AIS segment increased by 5%, representing 76% of the segment's revenues.

HIS Segment Growth

The HIS segment of CompuGroup Medical SE & Co. KGaA experienced a revenue increase of 7% to EUR 78 million in the first quarter of 2024. Organic revenue growth was 6%, mainly driven by revenues from the ongoing realization of projects related to the Hospital Future Act. Recurring revenues in this segment grew by 11% to EUR 57 million, accounting for 73% of the total segment revenue.

PCS Segment Analysis

In the PCS segment, CompuGroup Medical SE & Co. KGaA faced a slight decrease in revenue in the first quarter of 2024, down 2% year-over-year to EUR 34 million, influenced by one-time hardware sales in Italy. However, recurring revenues increased by 6% to EUR 25 million, making up 72% of the segment's total revenues.

Summarized from source with an LLMView Source

Key figures

-65.3%1Y
-83.3%3Y
%5Y

Performance

80.3%1Y
90.2%3Y
94.7%5Y

Volatility

Market cap

814 M

Market cap (USD)

Daily traded volume (Shares)

400

Daily traded volume (Shares)

1 day high/low

13.3 / 13.3

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Atkore Inc
Atkore Inc Atkore Inc Valor: 31850328
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.69%USD 85.01
MercadoLibre Inc
MercadoLibre Inc MercadoLibre Inc Valor: 3109814
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%USD 2,122.37
CrowdStrike Holdings Inc
CrowdStrike Holdings Inc CrowdStrike Holdings Inc Valor: 47976949
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.79%USD 259.13
The Trade Desk Inc
The Trade Desk Inc The Trade Desk Inc Valor: 33717137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.49%USD 106.06
Verisk Analytics Inc
Verisk Analytics Inc Verisk Analytics Inc Valor: 10595048
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%USD 268.79
Broadcom Inc
Broadcom Inc Broadcom Inc Valor: 41112361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.90%USD 167.69
Alarm.com Holdings Inc
Alarm.com Holdings Inc Alarm.com Holdings Inc Valor: 28367881
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.30%USD 55.25
MaxLinear Inc
MaxLinear Inc MaxLinear Inc Valor: 11132674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.43%USD 14.34
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc Sarepta Therapeutics Inc Valor: 19028527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.55%USD 124.65
Affirm Holdings Inc
Affirm Holdings Inc Affirm Holdings Inc Valor: 58463675
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.44%USD 44.01